Multi-Institutional Report Shows That AI Cancer Mentor
Dave Provides Valuable and Reliable Recommendations for Cancer
Patients and Caregivers, With a Positive Validation Of
91.8%
NEW
YORK, May 23, 2024 /PRNewswire/
-- Belong.Life, a leading global provider of AI-powered
patient education and support solutions, announced today that the
American Society of Clinical Oncology (ASCO) has published an
abstract in its 2024 Annual Meeting Book highlighting the positive
results of a multi-institutional validation report on Dave,
the company's conversational AI oncology mentor (abstract
#446530).
The survey was conducted by eight senior oncologists
specializing in various solid and haematological cancers and
affiliated with several leading medical institutions. The
oncologists assessed Dave's replies for their relevance and
helpfulness, aligning them with evidence-based medicine, current
recommendations, and guidelines.
471 patients and caregivers' questions answered by Dave
were randomly selected and categorized into groups, including
Breast, Gastrointestinal, Pancreatic, Genito-urinary,
Musculoskeletal and Hematological Cancers, and Radiation Therapy,
and reviewed by oncology specialists in those fields. Overall,
Dave achieved a positive validation percentage of nearly
92%, with only 1% graded as not at all helpful or relevant.
"This important validation evaluation, conducted by
leading oncologists, supports the accuracy and reliability of
an AI-powered Cancer Mentor in supporting the complex questions and
needs of people diagnosed with cancer," said Dr. Daniel Vorobiof,
renowned oncologist and Chief Medical Director of
Belong.Life. "Patients and caregivers turning to Dave
can rest assured that they are receiving valid information relevant
to their personal medical situation. We are strongly encouraged by
these excellent results as we continue exploring additional avenues
to expand quality AI support to assist patients, caregivers, and
physicians alike."
"We are proud to lead the medical community with the first and
most comprehensive specialized AI Cancer Mentor to accompany people
throughout their journeys," said Eliran
Malki, co-founder and CEO of Belong.Life. "Dave not
only improves patient knowledge and provides helpful and relevant
guidance but enables crucial coping mechanisms. This evaluation by
leading cancer experts attests to the high level of accuracy that
Dave delivers. We will continue evolving our efforts with
our BelongAI Health Mentor Series, making greater and more
accessible support to patients everywhere."
Launched in May 2023, Dave
is designed to provide uninterrupted support, clarify relevant
clinical issues, and guide patients and caregivers with supportive
and empathetic information and education, from diagnosis through
every other aspect of cancer management. Dave underwent
training on Belong's large proprietary datasets of patient-to-
physician and patient-to-patient interactions, and incorporates the
latest international cancer guidelines.
About Belong.Life
Belong.Life is leading the charge in elevating patient
engagement using conversational AI, big data and active patient
communities. Belong's key solutions include the world's largest
social and professional networks for people living with cancer
(Belong - Beating Cancer Together) and multiple
sclerosis (BelongMS), and the
BelongAI health-grade patient engagement and support platforms
(including Dave – Cancer
Mentor, Tara for clinical trial
matching and more) which utilize AI to proactively support and
empower patients throughout their healthcare journey. By enhancing
patient education and providing 24/7 support, as well as access to
relevant clinical trials, Belong is contributing to improved
healthcare outcomes globally. Belong's solutions are multilingual,
HIPAA, GDPR and ISO compliant.
For more information visit https://belong.life. Follow
Belong on
Facebook, X, and LinkedIn.
Media contact:
Aviva Sapir
FINN Partners for Belong.Life
aviva.sapir@finnpartners.com
+1-929-588-2014
View original
content:https://www.prnewswire.com/news-releases/abstract-published-in-asco-2024-annual-meeting-book-showcases-validity-of-belonglifes-conversational-ai-cancer-mentor-dave-302154332.html
SOURCE Belong.Life